Fonte: Cancer Research. Unidade: FMRP
Assuntos: NEOPLASIAS MAMÁRIAS, CARCINOMA DE DUCTOS INFILTRANTE, CITOCINAS, SOBREVIVÊNCIA LIVRE DE DOENÇA, REGULAÇÃO GÊNICA, EXPRESSÃO GÊNICA
ABNT
BENEVIDES, Luciana et al. IL17 promotes mammary tumor progression by changing the behavior of tumor cells and eliciting tumorigenic neutrophils recruitment. Cancer Research, v. 75, n. 8, p. 3788-3799, 2015Tradução . . Disponível em: https://doi.org/10.1158/0008-5472.CAN-15-0054. Acesso em: 22 ago. 2024.APA
Benevides, L., Fonseca, D. M. da, Donate, P. B., Tiezzi, D. G., Carvalho, D. D. de, Andrade, J. M. de, et al. (2015). IL17 promotes mammary tumor progression by changing the behavior of tumor cells and eliciting tumorigenic neutrophils recruitment. Cancer Research, 75( 8), 3788-3799. doi:10.1158/0008-5472.CAN-15-0054NLM
Benevides L, Fonseca DM da, Donate PB, Tiezzi DG, Carvalho DD de, Andrade JM de, Martins GA, Silva JS da. IL17 promotes mammary tumor progression by changing the behavior of tumor cells and eliciting tumorigenic neutrophils recruitment [Internet]. Cancer Research. 2015 ; 75( 8): 3788-3799.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1158/0008-5472.CAN-15-0054Vancouver
Benevides L, Fonseca DM da, Donate PB, Tiezzi DG, Carvalho DD de, Andrade JM de, Martins GA, Silva JS da. IL17 promotes mammary tumor progression by changing the behavior of tumor cells and eliciting tumorigenic neutrophils recruitment [Internet]. Cancer Research. 2015 ; 75( 8): 3788-3799.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1158/0008-5472.CAN-15-0054